Opportunity
Federal Register #2026-12614
NIH Center for Scientific Review Closed Meeting Notice for Grant Application Evaluation
Buyer
National Institutes of Health
Posted
June 23, 2026
Respond By
July 16, 2026
Identifier
2026-12614
This notice from the National Institutes of Health (NIH) Center for Scientific Review announces a series of closed virtual meetings for the review of grant applications: - Government Buyer: - Department of Health and Human Services (HHS) - National Institutes of Health (NIH) - Center for Scientific Review - Purpose: - Conduct closed meetings to review and evaluate grant applications in diverse scientific and medical research areas - Topics include gastroenterology, hepatology, nutrition, respiratory health, cellular and molecular mechanisms, heart, lung, blood, and sleep diseases, cancer mechanisms, biomedical technology, psychopathology, clinical care, infectious diseases, endocrinology, brain injury, drug and biomarker development, electronic medical records, neurodevelopment, radiation therapeutics, stem cell therapies, and urological systems - Confidentiality: - Meetings are closed to the public to protect confidential information, trade secrets, and personal privacy - Additional Information: - Notice includes reference to a data collection project (Chimpanzee Research Use Form) required for NIH-supported noninvasive research involving chimpanzees - No procurement activity: - No products, OEMs, or vendors are requested - Only service listed is the publication of the meeting notice - No purchase quantities or part numbers provided - No unique or notable procurement requirements specified
Description
This notice announces a series of closed meetings by the Center for Scientific Review at the National Institutes of Health. The meetings are scheduled for July 16-17, 2026, and will be conducted virtually. The purpose of these meetings is to review and evaluate grant applications related to various scientific and medical research topics. The meetings are closed to the public to protect confidential trade secrets, commercial property, and personal information associated with the grant applications.